MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Exploring the neural correlates of impulsivity and impulsive compulsive behaviors in Parkinson’s disease

    E. Ubeda Matzilevich, B. Swinnen, L. Ricciardi, S. Little (San Francisco, USA)

    Objective: To explore the subcortical neural correlates of impulse control and related behavioral disorders (ICBD) and trait impulsivity in a chronic and naturalistic setting in…
  • 2024 International Congress

    Analysing the bradykinesia features combination in people with Parkinson’s disease and elderly healthy individuals

    G. Paparella, M. de Riggi, A. Cannavacciuolo, D. Costa, D. Birreci, M. Passaretti, L. Angelini, A. Berardelli, M. Bologna (rome, Italy)

    Objective: To evaluate, through kinematic analysis, the major phenomenological features of bradykinesia, with a specific focus on their combination, in a relatively large sample of…
  • 2024 International Congress

    Muscle Augmentation Paradox: Contrasting Therapeutic Approaches in Myasthenia Gravis and Parkinson’s Disease

    G. Legerme, D. Nolasco, A. Sohel, A. Wu, B. Carr (Gainesville, USA)

    Objective: This exploration aims to dissect the therapeutic paradox presented by muscle augmentation strategies in Myasthenia Gravis (MG) and Parkinson's Disease (PD), offering a comparative…
  • 2024 International Congress

    Alterations in Monoamine Metabolites in Parkinson’s Disease: A Meta-Analysis

    MA. Muneer, V. Suresh, E. Zulfiqar, S. Saaki, I. Jaffery, V. Chowdary, S. Hurjkaliani (Lahore, Pakistan)

    Objective: To analyze the levels of various monoamine metabolites in patients with Parkinson’s Disease as compared to healthy controls. Background: Monoamine metabolites are the breakdown…
  • 2024 International Congress

    Education Levels on Diagnostic Delay Phase and Initial Symptom Perception Among Hispanic Patients with Parkinson’s Disease: A Cross-Sectional Study

    C. Rodriguez-Alarcon, D. Piana-Castillo, G. Faggioni-Sanchez, D. Bustamante-Mieles, M. Barreiro-Guillén, C. Cevallos-Velasco, R. Santibanez-Vasquez (Guayaquil, Ecuador)

    Objective: Determine the relationship between education levels and the diagnostic delay phase, along with the age of symptom perception, in Hispanic patients with Parkinson's disease…
  • 2024 International Congress

    Parkinson’s disease and Myasthenia Gravis: a case report and literature review

    C. Sánchez-Rodríguez, I. Muro, E. Casas, P. Lorenzo, C. Sanabria, A. Somovilla, L. López (Madrid, Spain)

    Objective: To present a case of comorbid Parkinson’s disease(PD) and Myasthenia Gravis(MG) and review the literature about the underlying pathogenesis mechanisms and potential treatments. Background:…
  • 2024 International Congress

    Ethnic Diversity and Symptomatology in Parkinson’s Disease with a Focus on Falls and Vertical Gaze Palsy

    D. Trivedi, C. Edwards, KC. Dey, E. Camboe, T. Haque, A. Joseph, J. Kahan, D. Gallagher, T. Boyle, C. Budu, B. Huxford, C. Simonet, S. Ganesh, A. Lee, C. Marshall, A. Noyce, A. Zirra (London, United Kingdom)

    Objective: The objective of this study was to explore atypical features in the clinical phenotype of people with Parkinson’s disease (PwP) enrolled in the East…
  • 2024 International Congress

    Passive smartphone speech monitoring in isolated rapid eye movement sleep behaviour disorder

    V. Illner, M. Novotny, T. Kouba, T. Tykalova, M. Simek, P. Sovka, J. Svihlik, E. Ruzicka, K. Sonka, P. Dusek, J. Rusz (Prague 6, Czech Republic)

    Objective: We aimed to design and test the sensitivity of a fully-automated and noise-resistant smartphone-based system that can unobtrusively screen for prodromal parkinsonian speech disorder…
  • 2024 International Congress

    Focused Ultrasound Therapy Treatment for Parkinson’s Disease

    Z. Muttalib, B. Syed, M. Alam, D. Nadora, U. Ansari, R. Sedighi, A. Vemulapalli, S. Asad (Elk Grove, USA)

    Objective: Parkinson’s Disease is a neurodegenerative disease that mainly affects the substantia nigra and nigrostriatal pathway and leads to rigidity, loss of muscle tone, tremors,…
  • 2024 International Congress

    Exploring Retrospectively the Predisposing Factors of Sleep Disorders in Parkinson’s Disease.

    SF. Arechavala Lopez, I. Fuentes Calvo, AJ. Hernández-Medrano, A. Cervantes-Arriaga, M. Rodríguez-Violante (CDMX, Mexico)

    Objective: Identify the predisposing or exacerbating factors of sleep disorders in Parkinson's disease, and examine their association with levodopa treatment. Background: Parkinson's disease (PD) is…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley